FASLG and diabetes mellitus: Activated B cells expressing FasL and TGF-β have also been reported to delay the onset of diabetes in non-obese diabetic (NOD) mice, and the frequency of FasL+ B cells is reduced in mice with severe autoimmune arthritis relative to those with mild or no arthritis [5], [18].